$3250 | Single User
$6500 | Site License
$9750 | Enterprise License

Acne vulgaris- Epidemiology Forecast to 2027 [Report Updated: 14-02-2018]

Published by Delve Insight: 14 Feb 2018 | 201357 | In Stock

Introduction

DelveInsight's "Acne vulgaris - Epidemiology Forecast, 2027” report provides a comprehensive analysis of the Acne vulgaris epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2027.

Markets Covered

• United States

• EU5 (Germany, France, Italy, Spain, and the United Kingdom)

• Japan

Study Period: 2016-2027

Acne vulgaris Epidemiology

The epidemiology section covers the historical, current as well as forecasted epidemiology for Acne vulgaris in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Acne vulgaris outlook. It also includes the explanation of changing trends of epidemiology outlining the Acne vulgaris scenario.

Acne vulgaris Epidemiology Segmentation

The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Acne vulgaris thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope

• The report covers detailed overview of Acne vulgaris explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns

• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan

• The Acne vulgaris Report assesses the disease risk and burden and highlights the unmet needs

• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths

• 10 Year Forecast

• 7MM Coverage

• Total Cases in Acne vulgaris

Key assessments

• Patient Segmentation in Acne vulgaris

• Acne vulgaris Risk & Burden

• Factors driving growth in a specific Acne vulgaris patient population

Table of Contents
for Acne vulgaris- Epidemiology Forecast to 2027 [Report Updated: 14-02-2018]

  • 1. Report Introduction

    2. Acne vulgaris Epidemiology Overview at a Glance

    2.1. Patient Share Distribution of Acne vulgaris in 2017

    2.2. Patient Share Distribution of Acne vulgaris in 2027

    3. Disease Background and Overview: Acne vulgaris

    3.1. Introduction

    3.2. Symptoms

    3.3. Etiology

    3.4. Risk Factors

    3.5. Pathophysiology

    3.6. Diagnosis

    3.7. Treatment

    4. Epidemiology and Patient Population

    4.1. Key Findings

    4.2. Total Prevalent/ Incident Patient Population of Acne vulgaris in 7MM

    4.3. Total Prevalent/ Incident Patient Population of Acne vulgaris in 7MM – By Countries

    5. Epidemiology of Acne vulgaris by Countries

    5.1. United States

    5.1.1. Assumptions and Rationale

    5.1.2. Prevalent/Incident Cases of the Acne vulgaris

    5.1.3. Sub-Type Specific cases of the Acne vulgaris *

    5.1.4. Sex- Specific Cases of the Acne vulgaris *

    5.1.5. Diagnosed Cases of the Acne vulgaris

    5.2. EU5

    5.3. Assumptions and Rationale

    5.4. Germany

    5.4.1. Assumptions and Rationale

    5.4.2. Prevalent/Incident Cases of the Acne vulgaris

    5.4.3. Sub-Type Specific cases of the Acne vulgaris *

    5.4.4. Sex- Specific Cases of the Acne vulgaris *

    5.4.5. Diagnosed Cases of the Acne vulgaris

    5.5. France

    5.5.1. Assumptions and Rationale

    5.5.2. Prevalent/Incident Cases of the Acne vulgaris

    5.5.3. Sub-Type Specific cases of the Acne vulgaris *

    5.5.4. Sex- Specific Cases of the Acne vulgaris *

    5.5.5. Diagnosed Cases of the Acne vulgaris

    5.6. Italy

    5.6.1. Assumptions and Rationale

    5.6.2. Prevalent/Incident Cases of the Acne vulgaris

    5.6.3. Sub-Type Specific cases of the Acne vulgaris *

    5.6.4. Sex- Specific Cases of the Acne vulgaris *

    5.6.5. Diagnosed Cases of the Acne vulgaris

    5.7. Spain

    5.7.1. Assumptions and Rationale

    5.7.2. Prevalent/Incident Cases of the Acne vulgaris

    5.7.3. Sub-Type Specific cases of the Acne vulgaris *

    5.7.4. Sex- Specific Cases of the Acne vulgaris *

    5.7.5. Diagnosed Cases of the Acne vulgaris

    5.8. United Kingdom

    5.8.1. Assumptions and Rationale

    5.8.2. Prevalent/Incident Cases of the Acne vulgaris

    5.8.3. Sub-Type Specific cases of the Acne vulgaris *

    5.8.4. Sex- Specific Cases of the Acne vulgaris *

    5.8.5. Diagnosed Cases of the Acne vulgaris

    5.9. Japan

    5.9.1. Assumptions and Rationale

    5.9.2. Prevalent/Incident Cases of the Acne vulgaris

    5.9.3. Sub-Type Specific cases of the Acne vulgaris *

    5.9.4. Sex- Specific Cases of the Acne vulgaris *

    5.9.5. Diagnosed Cases of the Acne vulgaris

    6. Unmet Needs of the Acne vulgaris

    7. Appendix

    8. Report Methodology

    8.1. Sources

    9. DelveInsight Capabilities

    10. Disclaimer

    11. About DelveInsight

    *Indication Specific

List Of Tables
in Acne vulgaris- Epidemiology Forecast to 2027 [Report Updated: 14-02-2018]

Table 1: Total Prevalent/Incident Cases of the Acne vulgaris in 7MM

Table 2: Total Prevalent/Incident Cases of the Acne vulgaris in 7MM by Countries

Table 3: Prevalent/Incident Cases of the Acne vulgaris in United States (2016-2027)

Table 4: Sub-Type Specific cases of the Acne vulgaris in United States (2016-2027)*

Table 5: Sex- Specific Cases of the Acne vulgaris in United States (2016-2027)*

Table 6: Diagnosed Cases of the Acne vulgaris in United States (2016-2027)

Table 7: Prevalent/Incident Cases of the Acne vulgaris in Germany (2016-2027)

Table 8: Sub-Type Specific cases of the Acne vulgaris in Germany (2016-2027) *

Table 9: Sex- Specific Cases of the Acne vulgaris in Germany (2016-2027) *

Table 10: Diagnosed Cases of the Acne vulgaris in Germany (2016-2027)

Table 11: Prevalent/Incident Cases of the Acne vulgaris in France (2016-2027)

Table 12: Sub-Type Specific cases of the Acne vulgaris in France (2016-2027) *

Table 13: Sex- Specific Cases of the Acne vulgaris in France (2016-2027) *

Table 14: Diagnosed Cases of the Acne vulgaris in France (2016-2027)

Table 15: Prevalent/Incident Cases of the Acne vulgaris in Italy (2016-2027)

Table 16: Sub-Type Specific cases of the Acne vulgaris in Italy (2016-2027) *

Table 17: Sex- Specific Cases of the Acne vulgaris in Italy (2016-2027) *

Table 18: Diagnosed Cases of the Acne vulgaris in Italy (2016-2027)

Table 19: Prevalent/Incident Cases of the Acne vulgaris in Spain (2016-2027)

Table 20: Sub-Type Specific cases of the Acne vulgaris in Spain (2016-2027) *

Table 21: Sex- Specific Cases of the Acne vulgaris in Spain (2016-2027) *

Table 22: Diagnosed Cases of the Acne vulgaris in Spain (2016-2027)

Table 23: Prevalent/Incident Cases of the Acne vulgaris in UK (2016-2027)

Table 24: Sub-Type Specific cases of the Acne vulgaris in UK (2016-2027) *

Table 25: Sex- Specific Cases of the Acne vulgaris in UK (2016-2027) *

Table 26: Diagnosed Cases of the Acne vulgaris in UK (2016-2027)

Table 27: Prevalent/Incident Cases of the Acne vulgaris in Japan (2016-2027)

Table 28: Sub-Type Specific cases of the Acne vulgaris in Japan (2016-2027) *

Table 29: Sex- Specific Cases of the Acne vulgaris in Japan (2016-2027) *

Table 30: Diagnosed Cases of the Acne vulgaris in Japan (2016-2027)

List Of Figures, Charts and Diagrams
in Acne vulgaris- Epidemiology Forecast to 2027 [Report Updated: 14-02-2018]

Table 1: Total Prevalent/Incident Cases of the Acne vulgaris in 7MM

Table 2: Total Prevalent/Incident Cases of the Acne vulgaris in 7MM by Countries

Table 3: Prevalent/Incident Cases of the Acne vulgaris in United States (2016-2027)

Table 4: Sub-Type Specific cases of the Acne vulgaris in United States (2016-2027)*

Table 5: Sex- Specific Cases of the Acne vulgaris in United States (2016-2027)*

Table 6: Diagnosed Cases of the Acne vulgaris in United States (2016-2027)

Table 7: Prevalent/Incident Cases of the Acne vulgaris in Germany (2016-2027)

Table 8: Sub-Type Specific cases of the Acne vulgaris in Germany (2016-2027) *

Table 9: Sex- Specific Cases of the Acne vulgaris in Germany (2016-2027) *

Table 10: Diagnosed Cases of the Acne vulgaris in Germany (2016-2027)

Table 11: Prevalent/Incident Cases of the Acne vulgaris in France (2016-2027)

Table 12: Sub-Type Specific cases of the Acne vulgaris in France (2016-2027) *

Table 13: Sex- Specific Cases of the Acne vulgaris in France (2016-2027) *

Table 14: Diagnosed Cases of the Acne vulgaris in France (2016-2027)

Table 15: Prevalent/Incident Cases of the Acne vulgaris in Italy (2016-2027)

Table 16: Sub-Type Specific cases of the Acne vulgaris in Italy (2016-2027) *

Table 17: Sex- Specific Cases of the Acne vulgaris in Italy (2016-2027) *

Table 18: Diagnosed Cases of the Acne vulgaris in Italy (2016-2027)

Table 19: Prevalent/Incident Cases of the Acne vulgaris in Spain (2016-2027)

Table 20: Sub-Type Specific cases of the Acne vulgaris in Spain (2016-2027) *

Table 21: Sex- Specific Cases of the Acne vulgaris in Spain (2016-2027) *

Table 22: Diagnosed Cases of the Acne vulgaris in Spain (2016-2027)

Table 23: Prevalent/Incident Cases of the Acne vulgaris in UK (2016-2027)

Table 24: Sub-Type Specific cases of the Acne vulgaris in UK (2016-2027) *

Table 25: Sex- Specific Cases of the Acne vulgaris in UK (2016-2027) *

Table 26: Diagnosed Cases of the Acne vulgaris in UK (2016-2027)

Table 27: Prevalent/Incident Cases of the Acne vulgaris in Japan (2016-2027)

Table 28: Sub-Type Specific cases of the Acne vulgaris in Japan (2016-2027) *

Table 29: Sex- Specific Cases of the Acne vulgaris in Japan (2016-2027) *

Table 30: Diagnosed Cases of the Acne vulgaris in Japan (2016-2027)

Additional Details

Publisher

Delve Insight

Publisher Information

DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver enduring results to deliver critical information to leading decision makers.



We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.

Reference

201357 | DIEI0003

Number of Pages

50

Report Format

PDF

Delve Insight Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Acne Vulgaris Global Clinical Trials Review, H2, 2018
Acne Vulgaris Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, “Acn...
25 Oct 2018 by Global Data USD $2,500 More Info
Acne And Related Disorders Global Clinical Trials Review, H2, 2018
Acne And Related Disorders Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial...
25 Oct 2018 by Global Data USD $2,500 More Info
Global Acne Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Nov 2016 by Current Partnering USD $1,495 More Info
Global Acne Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Acne Vulgaris Global Clinical Trials Review, H2, 2016
Acne Vulgaris Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial report, “Acn...
27 Jul 2016 by Global Data USD $2,500 More Info
Acne Vulgaris Global Clinical Trials Review, H2, 2016
Acne Vulgaris Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial report, “Acn...
27 Jul 2016 by Global Data USD $2,500 More Info
Acne Vulgaris Global Clinical Trials Review, H1, 2016
Acne Vulgaris Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial report, “Acn...
15 Apr 2016 by Global Data USD $2,500 More Info
Acne Vulgaris Global Clinical Trials Review, H1, 2016
Acne Vulgaris Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial report, “Acn...
15 Apr 2016 by Global Data USD $2,500 More Info
Acne And Related Disorders Global Clinical Trials Review, H2, 2015
Acne And Related Disorders Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial...
30 Nov 2015 by Global Data USD $2,500 More Info
Global Acne Treatment Market: Trends and Opportunities (2014-2019)
Scope of the ReportThe report titled “Global Acne Treatment Market: Trends and Opportunities (2014-2...
01 Jan 2015 by Daedal Research USD $800 More Info

This report is published by Delve Insight

DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver enduring results to deliver critical information to leading decision makers.

We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.

Download Free Report Summary PDF

Acne vulgaris- Epidemiology Forecast to 2027 [Report Updated: 14-02-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data